H.R. 9061

H.R. 9061: To amend title XIX of the Social Security Act to require the Secretary of Health and Human Services to issue guidance to States on which tests for the screening and early detection of preeclampsia may be covered under the Medicaid program and

Introduced Thomas Kean (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9061 aims to amend the Social Security Act to require the Secretary of Health and Human Services to provide guidance to states on which tests for screening and early detection of preeclampsia can be covered by the Medicaid program. This bill seeks to improve access to necessary medical tests for pregnant women at risk of preeclampsia, a serious condition that can affect both mothers and babies.

Positive Media Summary

Supporters of H.R. 9061 have praised it for potentially increasing access to vital healthcare services for pregnant women. The bill is seen as a proactive step towards addressing maternal health issues and ensuring that states have clear guidelines on Medicaid coverage for preeclampsia testing, which could lead to better health outcomes.

Negative Media Summary

Critics of H.R. 9061 have expressed concerns about the potential for increased costs to the Medicaid program. Some argue that the bill may lead to unnecessary testing or that it could complicate existing Medicaid guidelines. There are also fears that the guidance may not be comprehensive enough to ensure all necessary tests are covered.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of H.R. 9061, which focuses on Medicaid coverage for preeclampsia screening, reveals no direct industry overlaps between the bill's subject matter and the sponsor, Thomas Kean's, top donor industries. The primary lobbying activity in this area comes from various companies, including Viasat, Inc. and Southwest Airlines, which have contributed $20,000 each. However, these contributions are not directly related to healthcare or maternal health, indicating a low risk of conflict of interest. The absence of significant financial ties between the bill's focus and the sponsor's donor base suggests that the motivations behind the bill are likely not influenced by donor interests.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
REFORM ACTION FUND THE TOLMAN GROUP $30,000
VIASAT, INC. GORMAN STRATEGY GROUP, TOO $20,000
PHOTONIS LEWIS-BURKE ASSOCIATES, LLC $20,000
SOUTHWEST AIRLINES THE MONDELLO GROUP LLC $20,000
HUBBARD BROADCASTING STEPHEN WARD CONSULTING, LLC $20,000
ISTATION THE MONDELLO GROUP LLC undisclosed
LUMA ENERGY, LLC TRUE COMPASS, LLC undisclosed
SANTA FE FARMS, INC DBA ELEMENT6 DYNAMICS STEPHEN WARD CONSULTING, LLC undisclosed
LOUISIANA ENERGY SERVICES, LLC STEPHEN WARD CONSULTING, LLC undisclosed
CROSS COUNTRY HEALTHCARE, INC. MILLER STRATEGIES, LLC undisclosed
NUCOR CORPORATION MILLER STRATEGIES, LLC undisclosed
NEXUS HOSPICE OF THE HIGH DESERT LLC MILLER STRATEGIES, LLC undisclosed
TWG CADILLAC FORMULA 1 TEAM HOLDINGS, LLC MILLER STRATEGIES, LLC undisclosed
COSTAR GROUP, INC. MILLER STRATEGIES, LLC undisclosed
PADSPLIT, INC. CONTINENTAL STRATEGY, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Thomas Kean, ranked by total contributions.

Health Professionals $480,000,000
Individuals: $480,000,000 PACs: $0
Retired $150,000,000
Individuals: $150,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us